July 7, 2020 – FinCanna Management Subscribes to $500,000 of the Convertible Debenture
FinCanna Capital Corp. (“FinCanna“) (CSE:CALI)(OTCQB:FNNZF), a royalty company for the U.S. licensed medical cannabis industry announces the closing of its Convertible Debenture Financing for $2.5 million.
The subscription price is $1,000 per Unit. The Debentures will mature on February 8, 2023 and will bear interest at 12% per annum, payable in cash or, at the option of the Subscriber, in common shares of FinCanna subject to certain conditions. The Debenture is convertible into Common Shares at CAD$0.15 per share. Subscribers for Debentures will receive 5,000 common share purchase warrants for each Unit of principal amount of Debenture. Each Warrant will entitle the holder to acquire one Common Share of FinCanna for CAD$0.30 at any time up to the maturity date.
The FinCanna management team subscribed for $500,000 principal amount of the Debentures.
FinCanna intends to use the net proceeds from the Convertible Debenture to fund ongoing working capital and general corporate purposes as well selective royalty investment opportunities.
“We are very encouraged by the strong support from several key debenture holders, shareholders and management,” said Andriyko Herchak, CEO of FinCanna Capital. “These additional funds together with the previously announced extension of the convertible debentures, now maturing in February 2023, have significantly strengthened our balance sheet at a time when our investees are ramping up their sales and royalties for FinCanna, which we believe will have very meaningful impact to our bottom line.”
This press release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “1933 Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the 1933 Act and applicable state securities laws or an exemption from such registration is available.
The Canadian Securities Exchange has in no way passed upon the merits of the amendments to the terms of the outstanding Convertible Debentures and Warrants and new Convertible Debenture Financing and has neither approved nor disapproved the contents of this press release.
About FinCanna Capital Corp.
FinCanna is a royalty company that provides growth capital to rapidly emerging private companies operating in the licensed U.S cannabis industry. The company earns its revenue from royalties paid by its investee companies that are calculated based on a percentage their total revenues.
FinCanna’s scalable royalty model provides an attractive alternative or complement to debt or equity financing for its investee companies. FinCanna is focused on delivering high impact returns to its shareholders by way of a strategically diversified investment portfolio.
For additional information visit www.fincannacapital.com and FinCanna’s profile at www.sedar.com
FinCanna Capital Corp.
Andriyko Herchak, CEO & Director
This news release contains forward-looking information based on current expectations. Statements about, among other things, the use of proceeds of the Convertible Debenture financing, is forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance, or achievements to be materially different from those implied by such statements. Such factors include but are not limited to the Company may not use the proceeds of the Convertible Debenture financing as currently anticipated. Although such statements are based on management’s reasonable assumptions at the date such statements are made, actual results and future events could differ materially from those anticipated in such forward-looking information. Accordingly, readers should not place undue reliance on the forward-looking information. FinCanna assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
2020年7月7日- FinCanna Management 认购500,000美元可转换债券
FinCanna Capital Corp .(" FinCanna ")( CSE : CALI )( OTCQB : FNNZF ),一家美国特许医疗大麻行业的特许公司宣布以250万美元的价格完成可转换债券融资。
认购价为每单位1,000元。该等债券将于2023年2月8日到期，并将按每年12%的利率计息，以现金支付，或在认购方的选择下，按一定条件以 FinCanna 的普通股支付利息。债券可按每股0.15加元转换为普通股。债券的认购者将获得每单位债券本金5,000份普通股认股权证。每份认股权证将赋予持有人权利，以0.30加元在到期日之前的任何时间取得一股 FinCanna 普通股。
FinCanna Capital 首席执行官 Andriyko Herchak 表示：“几家主要债券持有人、股东和管理层的大力支持令我们非常鼓舞。”“这些额外的资金，加上此前宣布的可转换债券延期，现已于2023年2月到期，大大加强了我们的资产负债表，目前我们的投资对象正在加大对 FinCanna 的销售和特许权使用费，我们认为这将对我们的利润产生非常有意义的影响。”
关于 FinCanna Capital Corp 。
FinCanna 可扩展的特许权使用费模式为其投资公司提供了有吸引力的债务或股权融资选择或补充。FinCanna 专注于通过战略性多元化的投资组合，为股东带来高影响力的回报。
有关更多信息，请访问\160; www.fincanacacacapal.com 和 FinCanna 的个人资料，网址是\160; www.carder.com
FinCanna Capital Corp .
Andriyko Herchak ，首席执行官兼董事
本新闻稿包含基于当前预期的前瞻性信息。有关可转换债券融资收益使用等事项的声明是前瞻性信息。这些陈述不应被理解为对未来业绩或结果的保证。此类声明涉及已知和未知的风险、不确定性和其他因素，这些因素可能导致实际结果、业绩或成就与此类声明所暗示的结果、业绩或成就存在重大差异。该等因素包括但不限于本公司可能不会按目前预期使用可换股债券融资之所得款项。尽管该等陈述基于管理层于作出该等陈述之日的合理假设，但实际业绩及未来事件可能与该等前瞻性资料所预期的重大差异。因此，读者不应过分依赖前瞻性信息。除非适用法律要求， FinCanna 不承担更新或修订前瞻性信息以反映新事件或情况的责任。
这篇文章由 CFN Enterprises Inc .( OTCQB : CNFN )出版， CFN Media 是该行业领先的代理机构和数字金融媒体网络，致力于新兴的 CBD 和合法大麻行业。致电+1(833)420-CNFN 获取更多信息。